Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded new study sites in Krefeld (Germany), Valledupar (Colombia), Floridablanca (Colombia), Bogotá (Colombia), and Buenos Aires (Argentina), updated site contacts, and increased total locations to 761. Montpellier-related entries and other site records were removed or corrected as part of data cleanup.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdded site 007-436 in Pergamino, Argentina (B2700KMP) and updated contact details for Eva-Lotte Buchmeier (site 2217) and Ullrich Graeven (site 2221). The total number of locations is now 756.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded Instituto de Oncologia de Rosario (Site 007-5004) with Lucas Lucchesi Bosco; removed Sang-We Kim (Site 007-104). Updated the email line requirement to include NCT # and Site #, and added IPD sharing information with the provided URL and Revision: v3.4.1.SummaryDifference0.1%

- Check46 days agoChange DetectedStudy locations increased to 755 with new sites and contacts added, and certain contacts were removed or updated.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded recruitment site Tampereen Yliopistollinen Sairaala (TAYS) in Finland (Site 007-182) with investigator Jarkko Johannes Ahvonen; the site status updated to Recruiting. Updated the Last Update Posted timestamp to 2026-01-16.SummaryDifference0.0%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.